Immunoassay Expertise PBL Assay Science has 35 years of experience in immunoassays and biomarker testing services, offering a potential sales angle to prospects needing trusted interferon, cytokine proteins, antibodies, and multiplexed immunoassay kits for clinical and translational research.

Biomarker Focus Specialization in interferons and cytokines as key biomarkers positions PBL to target biotech and pharma customers with high-sensitivity and validated assays for disease stratification, treatment monitoring, and translational studies.

Clinical Study Enablement Extensive assay development, performance qualification, and biomarker testing services support sponsors in expediting clinical programs, presenting cross-sell opportunities for assay services alongside products.

Mid-Sized Advantage With 11-50 employees and revenue in the low tens of millions, PBL operates with agility and potential for personalized account management, making it suitable for targeted outreach to mid-market pharma and biotech firms seeking specialized assay partners.

Growth and Partnerships Existing relationships with multinational pharma, biotech, and academic institutions, plus a robust tech stack and e-commerce capabilities, create opportunities to expand product-line adoption, service bundles, and global collaboration through co-development and assay transfer services.